Bear Put Spread on Novo Nordisk A/S
Complete example: Bear Put Spread on Novo Nordisk (NVO) — including strikes, premium, break-even, and interactive payoff diagram.
Novo Nordisk A/S for Options Traders
Novo Nordisk A/S is the Danish pharma giant behind the GLP-1 blockbusters Ozempic and Wegovy, and one of Europe's most valuable companies. US options are accessible via its NYSE-listed ADRs (ticker NVO). News on trials, competition (Eli Lilly) and manufacturing capacity pushes volatility to an elevated level (IV 30-52%) — attractive for premium strategies with clearly defined risk.
Bear Put Spread — Quick Overview
The bear put spread is the bearish equivalent of the bull call spread. You buy a put with a higher strike and simultaneously sell a put with a lower strike. The sold put significantly reduces the net debit. This strategy profits from declining prices down to the short put strike. Maximum loss is the debit paid; maximum profit is the spread width minus debit.
Advantages
- Cheaper than a single long put (short put finances premium)
- Clearly defined maximum loss (debit paid)
- Fully participates in price decline down to the short strike
- Defined risk-reward profile
Disadvantages
- Maximum profit capped (decline below short strike not captured)
- Time decay works against you
- Two option transactions increase transaction costs
- IV increase helps, but not as strongly as with a single long put
Bear Put Spread on Novo Nordisk
Illustrative example based on a typical Novo Nordisk price of $85,00. Strikes and premiums are indicative — actual market prices will vary.
| Position | Type | Strike | Action | Premium |
|---|---|---|---|---|
| Long Put (purchased) | Put | $85,00 | Buy (debit) | -$4,76 |
| Short Put (sold) | Put | $77,50 | Sell (credit) | +$1,36 |
| Net debit paid | -$3,40 (-$340 per contract) | |||
Payoff Diagram at Expiration
Profit and loss of the Bear Put Spread on Novo Nordisk depending on the price at expiration. Values per contract (100 shares).
Why Bear Put Spread for Novo Nordisk?
Medium volatility offers good bear put spread setups with an attractive cost-benefit ratio. Buy ATM puts and sell puts 8-10% lower for a 3:1 to 4:1 profit-risk ratio. Particularly useful after strong rallies when the stock appears "overextended" and a consolidation is likely.
When is the right time?
- 1Bearish outlook with a clearly defined downside price target
- 2IV currently elevated — short put significantly reduces IV premium
- 3Cheaper alternative to buying a direct put
- 4Price target near the short put strike
- 5No upcoming positive event (earnings with bullish guidance expected)
Why Novo Nordisk for Options Traders
Novo Nordisk is one of Europe's most valuable companies and the market leader in GLP-1 drugs (Ozempic, Wegovy). Liquid US options are accessible via its NYSE-listed ADRs (ticker NVO). IV is elevated at typically 30-52%, driven by trial data, competition (Eli Lilly) and manufacturing capacity. For options traders NVO is an underlying with solid premiums and a clear fundamental story — suitable for defined-risk premium strategies.
Historical Context
Novo Nordisk saw an exceptional re-rating in 2021-2023 as Ozempic and Wegovy opened up the obesity market. Sharp pullbacks followed as disappointing trial data (including on next-generation drugs) and growing competitive pressure from Eli Lilly weighed on the valuation. These swings between euphoria and disappointment produce recurring IV spikes around trial results and quarterly reports. Traders should keep the calendar of clinical data and approval decisions in view.
FAQ: Bear Put Spread on Novo Nordisk
How do I trade Novo Nordisk options as a German investor?
What drives volatility on Novo Nordisk?
Is NVO suitable for conservative income strategies?
Bear Put Spread on other stocks
Other strategies for Novo Nordisk
Want to try this strategy yourself?
Use our free options tools for your own calculations — or discover more strategies on Novo Nordisk and other underlyings.